US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist
  • 6.510
  • +0.190+3.01%
Trading Mar 18 13:57 ET
177.67MMarket Cap-2170.00P/E (TTM)

About Fennec Pharmaceuticals Company

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Company Profile

SymbolFENC
Company NameFennec Pharmaceuticals
Listing DateSep 13, 2017
Founded1996
CEOMr. Jeffrey S. Hackman
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
AddressResearch Triangle Park,68 T.W. Alexander Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-919-636-4530

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey S. Hackman
  • Chief Executive Officer and Director
  • --
  • Terry Evans
  • Chief Commercial Officer
  • --
  • Robert Andrade
  • Chief Financial Officer and Principal Accounting Officer
  • 1.31M
  • Christiana Cioffi, M.B.A.
  • Chief Strategy Officer
  • --
  • Pierre S. Sayad, M.S.
  • Chief Medical Officer
  • --
  • Dr. Khalid Islam, PhD
  • Chairman of the Board
  • 225.23K
  • Rostislav Raykov
  • Director
  • 2.54M
  • Chris A. Rallis
  • Independent Director
  • 173.18K
  • Dr. Marco M. Brughera
  • Independent Director
  • 166.31K
  • Dr. Jodi A. Cook, PhD
  • Independent Director
  • 153.81K

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More